Pages that link to "Q35158481"
Jump to navigation
Jump to search
The following pages link to Addressing the safety of anakinra in patients with rheumatoid arthritis (Q35158481):
Displaying 13 items.
- Interleukin-1 receptor antagonist for treating periodontitis (Q24199001) (← links)
- Interleukin-1 receptor antagonist for treating periodontitis (Q24240691) (← links)
- Blood gene expression profiling in pediatric systemic lupus erythematosus and systemic juvenile idiopathic arthritis: from bench to bedside (Q33622723) (← links)
- Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis (Q36062038) (← links)
- Biological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs. (Q37390458) (← links)
- Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations (Q37924648) (← links)
- Safety of biologic therapy in rheumatoid arthritis (Q37944433) (← links)
- Assessing the safety of biologic agents in patients with rheumatoid arthritis (Q38020463) (← links)
- New biologic-response modifiers in ocular inflammatory disease: beyond anti-TNF treatment. (Q38057370) (← links)
- Anti-Inflammatory Effects of Modified Adenoviral Vectors for Gene Therapy: A View through Animal Models Tested. (Q38849248) (← links)
- An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX). (Q42663316) (← links)
- Interleukin-1 blockade in neuro-Behçet's disease: a case-based reflection (Q58326027) (← links)
- Treatment of rheumatoid arthritis with anakinra: a systematic review (Q84600283) (← links)